When VC aMoon was established in 2017, "the premise was to invest heavily in the convergence of technology and biology, healthcare and data," says Dr. Yair Schindel, its Managing Partner. "Now we see things happening that we only expected to see three or five years from now," says Schindel. "In that sense, Covid put everything on steroids."
Trending:
'Covid put everything on steroids,' says prominent healthtech investor